<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00811161</url>
  </required_header>
  <id_info>
    <org_study_id>AR12345</org_study_id>
    <nct_id>NCT00811161</nct_id>
  </id_info>
  <brief_title>An Open Label Study to Evaluate the Efficacy of Airgent in Treating Damaged and Wrinkled Skin</brief_title>
  <official_title>An Open Label Study to Evaluate the Efficacy of Airgent in Treating Damaged and Wrinkled Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PerfAction Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PerfAction Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to Evaluate the effectiveness of treatment of wrinkles
      or damaged skin with the Airgent device.

      The secondary objective of this study are to:

        -  Evaluate subjects' satisfactory of the treatment.

        -  Demonstrate the safety of the Airgent treatment by evaluation of adverse events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each subject will attend the clinic for the screening visit, 3 or 4 treatment visits 3-4
      weeks apart, and number of follow-up visits (three at least). Evaluation of results of the
      performed treatments will be performed in course of the next treatment visit (prior to
      performance the next treatment) and at follow-up visits at 1, 3 and 6 months after the last
      treatment in session. Additional evaluation visits at 9 and 12 months after completion the
      treatment session can be performed upon decision of the investigator in case when
      considerable improvement is recorded during the 6-months evaluation visit.

      Biopsies from up to five subjects treated for stretch marks will be collected at the time of
      3-months evaluation visit, from treated and untreated zone (one of each).

      Subjects will be requested to refrain from using any other method of skin rejuvenation for
      the entire duration of the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator/sub investigator assessment based on direct observation and photographs compared to baseline evaluation.</measure>
    <time_frame>3-12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>recording of adverse events.</measure>
    <time_frame>1-3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate subjects' satisfactory of the treatment</measure>
    <time_frame>1-12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Wrinkles or Damaged Skin Condition</condition>
  <arm_group>
    <arm_group_label>needle free injector of HA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Airgent</intervention_name>
    <description>HA needle free injection, 3-4 treatments, 3-4 weeks apart</description>
    <arm_group_label>needle free injector of HA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females and males in good general health 18-65 years old

          -  Subject that are capable of reading, following directions, and understanding the
             procedure to be applied and that are obligated to forgo any other method of skin
             rejuvenation treatment for the entire study period.

        Exclusion Criteria:

          -  Medical or psychiatric conditions that can affect the subject's ability to give
             informed consent, or complete the study.

          -  Pregnant or lactating females.

          -  Other known diseases including diabetes, autoimmune disorders, epilepsy, severe
             migraines chronic liver or kidney

          -  Disease or contagious diseases, such as HIV or hepatitis

          -  Participation in a clinical trial within the last 30 days.

          -  Subjects on any medication (chronic use) that would affect the characteristic of the
             skin (medical or hormonal), such as NSAID, blood thinning medications,
             immunosuppressive drugs, steroids, vitamin E supplements and Isotretinoins within one
             month prior to enrollment.

          -  Subjects who have any form of suspicious lesion on the treatment area.

          -  Subjects with history of keloid formations or hypertrophic scarring.

          -  Subjects with permanent makeup/ tattoo (in the treated area).

          -  Subjects with any cutaneous inflammation on the treatment area such as herpes or acne.

          -  Subjects with known sensitivity to hyaluronic acid or to egg products.

          -  Subjects with clotting disorders.

          -  Subjects addicted to drug or alcohol.

          -  Subjects who underwent any aesthetic procedure in the treated area or adjacent to it.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dean D. AD-EL D. AD-EL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dean D. AD-EL, MD</last_name>
    <phone>+972 3 937 6366</phone>
    <email>deana@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah Tiqwa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean D. AD-EL, MD</last_name>
      <phone>+972 3 937 6366</phone>
      <email>deana@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Dean AD-EL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oren Ganor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2008</study_first_submitted>
  <study_first_submitted_qc>December 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2008</study_first_posted>
  <last_update_submitted>June 3, 2009</last_update_submitted>
  <last_update_submitted_qc>June 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Dean D. AD-E/ Head, Department of Plastic Surgery &amp; Burn Unit</name_title>
    <organization>Rabin Medical Center</organization>
  </responsible_party>
  <keyword>Remodeling</keyword>
  <keyword>Airgent</keyword>
  <keyword>Hyaluronic acid</keyword>
  <keyword>Collagen formation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

